- Home
- CDXS vs WALD Comparison
CDXS vs WALD Comparison
Compare CDXS & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- WALD
- Stock Information
- Founded
- CDXS 2002
- WALD 1988
- Country
- CDXS United States
- WALD United States
- Employees
- CDXS N/A
- WALD N/A
- Industry
- CDXS Major Chemicals
- WALD Package Goods/Cosmetics
- Sector
- CDXS Industrials
- WALD Consumer Discretionary
- Exchange
- CDXS Nasdaq
- WALD Nasdaq
- Market Cap
- CDXS 216.6M
- WALD 238.6M
- IPO Year
- CDXS 2010
- WALD 2021
- Fundamental
- Price
- CDXS $2.56
- WALD $1.99
- Analyst Decision
- CDXS Buy
- WALD Strong Buy
- Analyst Count
- CDXS 2
- WALD 5
- Target Price
- CDXS $11.00
- WALD $4.96
- AVG Volume (30 Days)
- CDXS 538.3K
- WALD 133.9K
- Earning Date
- CDXS 10-30-2025
- WALD 11-11-2025
- Dividend Yield
- CDXS N/A
- WALD N/A
- EPS Growth
- CDXS N/A
- WALD N/A
- EPS
- CDXS N/A
- WALD N/A
- Revenue
- CDXS $57,164,000.00
- WALD $273,868,000.00
- Revenue This Year
- CDXS $12.88
- WALD $10.37
- Revenue Next Year
- CDXS $21.64
- WALD $14.37
- P/E Ratio
- CDXS N/A
- WALD N/A
- Revenue Growth
- CDXS N/A
- WALD 25.55
- 52 Week Low
- CDXS $1.90
- WALD $1.48
- 52 Week High
- CDXS $6.08
- WALD $4.18
- Technical
- Relative Strength Index (RSI)
- CDXS 51.47
- WALD 56.70
- Support Level
- CDXS $2.41
- WALD $1.82
- Resistance Level
- CDXS $2.73
- WALD $1.97
- Average True Range (ATR)
- CDXS 0.12
- WALD 0.11
- MACD
- CDXS 0.03
- WALD -0.00
- Stochastic Oscillator
- CDXS 55.26
- WALD 57.38
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.